A comprehensive view of sanofi sa. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

SK Bioscience to expand its L House vaccine plant in Andong, South Korea, to manufacture next-gen GBP410 pneumococcal vaccine it is developing with Sanofi; vaccine entering global Phase III clinical trial
Published: November 28, 2023 by Contify Life Science News
Sanofi reports 34% reduction in COPD exacerbations in second Phase 3 trial of Dupixent, plans to submit BLA by end of 2023; nearly 300,000 people in US have uncontrolled COPD with type 2 inflammation
Published: November 27, 2023 by EquityBites
BioNTech scores win in ongoing vaccine patent war as European Patent Office invalidates one of Moderna's patents for respiratory virus vaccines; Moderna plans to appeal the decision
Published: November 22, 2023 by FiercePharma
GoodRx partnering with Sanofi to offer the insulin medication Lantus at flat rate of US$35 to both insured and uninsured diabetes patients in the US; the offer is available at over 70,000 US pharmacies accepting Good Rx, effectively immediately
Published: October 19, 2023 by GoodRx Inc.
Report predicts pharma industry set to grow 4% annually, with earnings increasing 7% annually, from 2023 to 2030; growth to be led by Eli Lilly, Novo Nordisk, AstraZeneca, Roche, Sanofi, Pfizer and GSK: TD Cowen
Published: October 04, 2023 by FiercePharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count